Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00178503 · ClinicalTrials.gov registry record · Phase 2

Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children

A Phase 2 study of Autism and Attention Deficit Disorder With Hyperactivity, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
Phase 2
Development phase
24
Enrollment target
1
Study location

NCT00178503 is a Phase 2 study of Autism and Attention Deficit Disorder With Hyperactivity that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 24 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00178503, a Phase 2 study of Autism and Attention Deficit Disorder With Hyperactivity, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
Phase 2
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

This study examined the cognitive and behavioral differences in children who have an autism spectrum disorder (ASD) with or without additional symptoms of ADHD. The study also examined the effectiveness of a range of doses of methylphenidate in improving cognitive and behavioral outcomes in children with both ASD and ADHD.

Conditions Studied

Autism Attention Deficit Disorder With Hyperactivity

Interventions

  • OTHER Placebo
  • DRUG Methylphenidate-extended release
  • DRUG Methylphenidate-immediate release

Study Locations (1)

Texas

  • University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2005-09
Est. Completion 2011-05
Phase Phase 2

Sponsor

The University of Texas Health Science Center, Houston

732 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00178503

The ClinicalTrials.gov registry entry for NCT00178503 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 183-participant average among 104 other Autism trials with a reported enrollment target (87% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT00178503 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00178503 about?

NCT00178503 is a clinical study titled "Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children". This study examined the cognitive and behavioral differences in children who have an autism spectrum disorder (ASD) with or without additional symptoms of ADHD. The study also examined the effectiveness of a range of doses of methylphenidate in improving cognitive and behavioral outcomes in children...

What is the current status of trial NCT00178503?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2005-09. Estimated completion is 2011-05.

What conditions does trial NCT00178503 study?

This clinical trial studies the following conditions: Autism, Attention Deficit Disorder With Hyperactivity.

What interventions are being tested in trial NCT00178503?

The interventions under investigation include: Placebo (OTHER), Methylphenidate-extended release (DRUG), Methylphenidate-immediate release (DRUG).

Who is sponsoring clinical trial NCT00178503?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00178503 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Autism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Autism

All registered trials for this condition

Attention Deficit Disorder With Hyperactivity

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.